Unlike normal bleeding, which occurs only when a woman is not pregnant, endometrial cancer is higher in the uterus. Although the disease is not recognizable through a Pap smear, certain changes on the test may indicate cancer. If this is the case, a doctor will perform a further diagnostic procedure. Treatment for cancer endometrial in is highly individual and depends on the stage of the disease and overall health of the patient. It may require additional therapies, including chemotherapy and hormone therapy.
Surgical pathologic findings may also influence the prognosis of endometrial cancer. Women diagnosed with high-grade endometrial cancer, as well as women with a clear-cell type of tumor, are at increased risk of developing a second type of cancer. A recent study published in the Journal of the American College of Surgeons has shown a higher risk of developing a second type of cancer in women with endometrial cancer, including breast and colon cancer.
Detecting cancer endometrial is often done through biopsy or a probe during dilatare or chiuretaj. In rare cases, the Papanicolau test will reveal the presence of cancer endometrial. The median age of women diagnosed with cancer endometrial is seventy years. However, most women diagnosed with cancer endometrial are younger than 70 years of age.
Endometrial cancer is most common among women of childbearing age. It is caused by mutations that transform normal cells into abnormal ones. Healthy cells grow and die at a certain rate and die at a set time. Abnormal cells grow out of control and do not die at a set time, forming a mass. These cancer cells then invade nearby tissues and spread to other parts of the body. Women who are pregnant may be more at risk of cancer endometrial in, as the hormones they produce can alter the lining of the uterus.
Treatment for cancer endometrial in includes surgery to remove the uterus, fallopian tubes, and ovaries. Lymph glands may also be removed to check for spread of the disease. Surgical procedures include total hysterectomy or salpingectomy. These operations remove the endometrium and the cervix and may also involve surgery. Fortunately, the majority of endometrial cancer patients survive the five-year mark.
Cytological findings of endometrial cancer will determine the stage of the disease. A positive result from cytology is an indication that the cancer has spread to lymph nodes. The FIGO staging system specifies that a tumor in the pelvis or lower abdomen has reached a clinical stage I. Lymph node evaluation is also an important part of cancer endometrial invoicing. In addition to cytological testing, the underlying disease should be biopsyed to determine if there are any metastases in the body.
Some women who have cancer endometrial may experience pain during sexual activity or in the pelvis. These symptoms are similar to those associated with endometriozei, but pulmonary imaging and biopsy are necessary to determine the exact cause. However, pulmonary imaging can be used to detect cancer endometrial invoicing in women. The symptoms and diagnosis of cancer endometrial in women vary widely. If these symptoms seem familiar, it is important to seek medical attention as early as possible.
